We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Advaite

News List

FDA GRANTS ADVAITE EMERGENCY USE AUTHORIZATION FOR RapCov™ Rapid COVID-19 Test prnewswire
January 13, 2021
The U.S. Food and Drug Administration has granted Emergency Use Authorization (EUA) to one of the first U.S.-manufactured serology tests designed by ADVAITE Inc., an innovative biotech company developing novel point-of-care assays to help with ...
FDA Grants Advaite Emergency Use Authorization FOR RapCov Rapid COVID-19 Test americanpharmaceuticalreview
January 13, 2021
The U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) to one of the first U.S.-manufactured serology tests designed by ADVAITE.
ADVAITE CLIA Lab Receives Authorization to Offer COVID-19 SalivaDirect Test americanpharmaceuticalreview
November 23, 2020
ADVAITE announced the company's high complexity CLIA laboratory operating out of Chicago, IL has been authorized to offer Yale University's SalivaDirect™ test.
Advaite Produces COVID-19 Rapid Response Diagnostic Kits contractpharma
March 16, 2020
Diagnostic testing kit, ADVAITE RAPCOV, has ability to provide results in 15-30 minutes from a drop of fingertip blood and offers a solution for mass screening.